Active Implants LLC, a company that develops orthopedic implant solutions, announces that it has reached an exclusive agreement with Geistlich Pharma AG to be the exclusive Swiss distributor of the company’s NUsurface Meniscus Prothesis. The world’s first “artificial...
Two-year results from the MERCURY study suggests that the NUsurface Meniscus Implant provides statistically superior pain relief beginning at 6 months compared to non-surgical therapy, Active Implants LLC reports. The results were presented at the American...
Active Implants LLC announces that the final patient was treated in the two clinical trials evaluating the NUsurface Meniscus Implant for the treatment of persistent knee pain caused by injured or deteriorated meniscus tissue. The SUN (Safety Using NUsurface) and...
